Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes
NCT ID: NCT02542774
Last Updated: 2015-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80000 participants
OBSERVATIONAL
2015-08-31
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Approach of Cardiovascular Risk Factors in T2DM by Gender
NCT04653805
Diabetes in Primary Care - Improving Classification
NCT06711718
Exercise and Type 2 Diabetes: Gender and Endothelial Function
NCT01993121
Exercise Training in Older Diabetic Women
NCT00341614
A Diabetes Prevention Study Targeting High Risk Individuals With Education and Ongoing Support
NCT00677937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this research isto evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention is given.
This study is based on the analysis of linked electronic health records (CALIBER dataset)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Data collected in the period 1997-2010
* Minimum time since registration of 1 year
* Minimum of 1 year of up to standard data (CPRD quality standard)
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanne Peters
Role: STUDY_DIRECTOR
The George Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The George Institute for Global Health, Nuffield Department for Population Health, University of Oxford
Oxford, Oxford, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15_108R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.